Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Dabomb Protein Biotech Corporation (6578) Income Statement

Dabomb Protein Biotech Corporation Income Statement

Last quarter (Q2 2026), Dabomb Protein Biotech Corporation's total revenue was NT$107.48M, an increase of 18.28% from the same quarter last year. In Q2, Dabomb Protein Biotech Corporation's net income was NT$9.19M. See Dabomb Protein Biotech Corporation’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 309.33MNT$ 337.82MNT$ 384.41MNT$ 433.63MNT$ 470.63M
NT$ 69.03MNT$ 68.73MNT$ 46.43MNT$ 19.33MNT$ 21.65M
NT$ 97.22MNT$ 70.55MNT$ 76.36MNT$ 81.80MNT$ 85.42M
Depreciation and AmortizationNT$ 41.02MNT$ 13.71MNT$ 21.72MNT$ 26.99MNT$ 26.24M
NT$ -22.25MNT$ 34.98MNT$ -26.00MNT$ -15.49MNT$ -40.80M
NT$ -28.18MNT$ -1.82MNT$ -29.93MNT$ -42.48MNT$ -67.04M
NT$ -38.16MNT$ 17.89MNT$ -26.02MNT$ 13.42MNT$ -7.85M
NT$ -66.34MNT$ 16.07MNT$ -55.95MNT$ -49.05MNT$ -71.62M
NT$ -69.34MNT$ 11.64MNT$ -57.02MNT$ -44.66MNT$ -62.45M
Per Share Metrics
Basic EPSNT$ -0.96NT$ 0.17NT$ -1.07NT$ -1.15NT$ -1.92
Diluted EPSNT$ -0.96NT$ 0.17NT$ -1.07NT$ -1.15NT$ -1.92
Weighted Average Shares Outstanding72.23M66.82M53.29M38.70M32.47M
Weighted Average Shares Outstanding (Diluted)72.23M71.86M53.50M38.70M32.47M

Currency in TWD

Dabomb Protein Biotech Corporation Earnings and Revenue History

-400M0400M800M-24 %-12 %0 %12 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin